A chest X-Ray is the first line of investigation for pneumonia. It’s the most readily available, quick and cost-effective imaging tool for the diagnosis of pneumonia – the number one killer of patients with COVID-19 and TB.
RADIFY® detects 16 major abnormalities on chest X-rays – including TB and COVID-19 pneumonia-related pathologies. It can label and prioritize over 2000 x-rays per minute.
A chest X-Ray is the first line of investigation for pneumonia. It’s the most readily available, quick and cost-effective imaging tool for the diagnosis of pneumonia – the number one killer of patients with COVID-19 and TB.
In 2019, an estimated 10 million people fell ill with tuberculosis (TB) worldwide, of which, 1.2 million where children, yet TB is curable and preventable.
An innovative medical technology company using Artificial Intelligence to transform medical imaging diagnosis.
Trained and validated by radiologists for medical practitioners, our products detect and highlight abnormalities on medical imaging.
This product is licensed with SAHPRA as a Class A Medical Device as a medical image management system application software. This product is for professional and academic use.
2020-2022 © Envisionit Deep AI (Pty) Ltd. 2019/038117/07. All Rights Reserved. Terms & Conditions Apply.
Data privacy is a human right. Envisionit Deep AI™ is committed to the privacy and confidentiality of information provided to us in compliance with all relevant legislation, including the Protection of Personal Information Act, 2013 (“POPI”) and General Data Protection Regulation (GDPR) (EU) 2016/679.
Welcome! We use cookies – Cookies tell us which parts of our websites you visited, help us measure the effectiveness of ads and web searches, and give us insights into user behaviour, so that we can improve our communications and products. Learn more about this in our Privacy Policy.